首页|刘良徛辨治新冠肺炎后肺纤维化验案举隅

刘良徛辨治新冠肺炎后肺纤维化验案举隅

扫码查看
原文链接
  • 万方数据
  • 维普
严重急性呼吸系统综合征冠状病毒2型具有极强的传染性,多数患者在病程后期出现不同程度的炎症后肺纤维化,伴随胸闷气短、咳嗽咳痰等症状.以国医大师洪广祥"治肺不远温"的学术思想为指导,刘良徛活用温散、温化、温补、温通等治法及温胆汤、温肺化纤汤、补元汤等方剂,成功改善新冠病毒肺炎后肺纤维化患者症状,且疗效显著.
Example of Experience Medical Record of Pulmonary Fibrosis after COVID-19 Treated by LIU Liangji
The SARS-CoV-2 is highly contagious.Most patients suffer from different degrees of post-inflammatory pulmonary fibrosis in the later stages of the disease,accompanied by chest tightness and shortness of breath,cough and phlegm.LIU Liangji,centering on HONG Guangxiang's academic thought of"treating lung not far from warmming",a master of traditional Chinese medicine,flexibly adopted the therapeutic methods of warming and scattering,warming and eliminating,warming and tonifying,warming and dredging,and used the prescriptions of Wendan Decoction,Wenfei Huaxian Decoction,and Buyuan Decoction to treat a case of pulmonary fibrosis after COVID-19,achieving remarkable effect.

Pulmonary Fibrosis after COVID-19Treating Lung not Far from WarmmingExperience Medical Record

余亦程、莫丽莎、许越淇、刘良徛

展开 >

江西中医药大学 南昌 330004

江西中医药大学附属医院 南昌 330006

新冠病毒肺炎后肺纤维化 治肺不远温 验案

国医大师洪广祥全国名老中医药专家传承工作室项目国家自然科学基金项目中央引导地区科技发展项目江西省中医肺病学重点实验室项目江西省研究生创新专项江西中医药大学科技创新团队发展计划项目

国中医药人教发[2014]20号8186082620222ZDH0109692024SSY06321YC2023-B231CXTD22011

2024

10.20140/j.2095-7785.2024.04.04

江西中医药大学学报
江西中医学院

江西中医药大学学报

影响因子：0.575
ISSN：2095-7785
年,卷(期)：2024.36(4)